ML20153B854

Takes Exception to Position of Draft NUREG-1633,as One of Two FDA-approved Suppliers of Potassium Iodide for Use as thyroid-blocking Agent in Radiation Emergency.List of Concerns Submitted
Person / Time
ML20153B854
Issue date:	09/03/1998
From:	Morris A ANBEX, INC.
To:	Mohseni A NRC
Shared Package
ML20153B539	List: ML20153B571 ML20153B597 ML20153B609 ML20153B630 ML20153B638 ML20153B729 ML20153B735 ML20153B743 ML20153B755 ML20153B760 ML20153B789 ML20153B817 ML20153B826 ML20153B829 ML20153B836 ML20153B846 ML20153B854 ML20153B870 ML20153B890 ML20153B901 ML20153B927 ML20153B942 ML20153B961 ML20153C020 ML20153C143 ML20153C188 ML20153C194
References
RTR-NUREG-1633 NUDOCS 9809230268
Download: ML20153B854 (5)
v • d • e

v t e Similar Documents from Morris A, INC., ANBEX
Category:CORRESPONDENCE-LETTERS [Table view]Some use of "" in your query was not closed by a matching "". Category:INCOMING CORRESPONDENCE [Table view]Some use of "" in your query was not closed by a matching "".

Navigation menu